SWK Holdings Corp
NASDAQ:SWKH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (10.6), the stock would be worth $-2.21 (114% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -75.9 | $15.9 |
0%
|
| 3-Year Average | 10.6 | $-2.21 |
-114%
|
| 5-Year Average | 10.4 | $-2.18 |
-114%
|
| Industry Average | 16.5 | $-3.45 |
-122%
|
| Country Average | 22.9 | $-4.79 |
-130%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
$192.3m
|
/ |
Jan 2026
$-2.5m
|
= |
|
|
$192.3m
|
/ |
Dec 2026
$25.9m
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
S
|
SWK Holdings Corp
NASDAQ:SWKH
|
192.3m USD | -75.9 | |
| IN |
S
|
SPS Finquest Ltd
BSE:538402
|
2.6T INR | 877 228.1 | |
| TR |
D
|
Destek Finans Faktoring AS
IST:DSTKF.E
|
857.5B TRY | 227.7 | |
| IN |
|
Power Finance Corporation Ltd
NSE:PFC
|
1.5T INR | 5.8 | |
| IN |
|
Indian Railway Finance Corp Ltd
NSE:IRFC
|
1.4T INR | 19.4 | |
| JP |
|
Mitsubishi HC Capital Inc
TSE:8593
|
2.1T JPY | 11.2 | |
| IN |
|
REC Limited
NSE:RECLTD
|
957.3B INR | 5.4 | |
| JP |
|
Shinkin Central Bank
TSE:8421
|
1.7T JPY | 57.1 | |
| CA |
|
Element Fleet Management Corp
TSX:EFN
|
12.7B CAD | 45.6 | |
| JP |
|
Tokyo Century Corp
TSE:8439
|
1.1T JPY | 8.3 | |
| TW |
|
Chailease Holding Company Ltd
TWSE:5871
|
202.8B TWD | 10.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.3 |
| Median | 22.9 |
| 70th Percentile | 33.2 |
| Max | 1 826 183.3 |
Other Multiples
SWK Holdings Corp
Glance View
SWK Holdings Corp. is engaged in the business of financial and asset management in the field of pharmaceutical. The company is headquartered in Dallas, Texas and currently employs 35 full-time employees. The firm is focused on providing various capital solutions to a range of life science companies, institutions and inventors. The firm operates through two segments: Finance Receivables and Pharmaceutical Development. Its Finance Receivables segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. In addition, through its wholly owned subsidiary, SWK Advisors LLC, it provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. Through its subsidiary, Enteris BioPharma, Inc., its Pharmaceutical Development segment offers formulation solutions built around its oral drug delivery technology, the Peptelligence platform.
